These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 18164507
1. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE. J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507 [Abstract] [Full Text] [Related]
2. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J. Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [Abstract] [Full Text] [Related]
3. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P. Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296 [Abstract] [Full Text] [Related]
4. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients. Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P. Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832 [Abstract] [Full Text] [Related]
5. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE. Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1349-57. PubMed ID: 17059516 [Abstract] [Full Text] [Related]
6. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C. Vidali M, Occhino G, Ivaldi A, Rigamonti C, Sartori M, Albano E. Am J Gastroenterol; 2008 Jan 01; 103(1):147-53. PubMed ID: 18184121 [Abstract] [Full Text] [Related]
8. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A. Am J Gastroenterol; 2008 May 01; 103(5):1136-44. PubMed ID: 18477344 [Abstract] [Full Text] [Related]
9. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Cua IH, Hui JM, Kench JG, George J. Hepatology; 2008 Sep 01; 48(3):723-31. PubMed ID: 18688878 [Abstract] [Full Text] [Related]
10. Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype. Oliveira AC, Parise ER, Catarino RM, Lanzoni V, Leite-Mor MM, Simon KA, Junqueira VB. Free Radic Res; 2009 Dec 01; 43(12):1187-94. PubMed ID: 19905981 [Abstract] [Full Text] [Related]
11. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Antò M, Capasso R, Zappia V, Ruggiero G. Hepatology; 2005 May 01; 41(5):995-1003. PubMed ID: 15834927 [Abstract] [Full Text] [Related]
12. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study. Tsochatzis E, Manolakopoulos S, Papatheodoridis GV, Hadziyannis E, Triantos C, Zisimopoulos K, Goulis I, Tzourmakliotis D, Akriviadis E, Manesis EK, Archimandritis AJ. Aliment Pharmacol Ther; 2009 Nov 01; 30(9):947-54. PubMed ID: 19604179 [Abstract] [Full Text] [Related]
13. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4. Ashour E, Samy N, Sayed M, Imam A. Clin Lab; 2010 Nov 01; 56(3-4):103-10. PubMed ID: 20476641 [Abstract] [Full Text] [Related]
15. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L. Gut; 2005 Jul 01; 54(7):1003-8. PubMed ID: 15951550 [Abstract] [Full Text] [Related]
16. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, Kench JG, George J. J Hepatol; 2008 Jan 01; 48(1):28-34. PubMed ID: 17977612 [Abstract] [Full Text] [Related]
18. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Hsu CS, Liu CJ, Liu CH, Wang CC, Chen CL, Lai MY, Chen PJ, Kao JH, Chen DS. Liver Int; 2008 Feb 01; 28(2):271-7. PubMed ID: 18028320 [Abstract] [Full Text] [Related]
19. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Romero-Gómez M, Castellano-Megias VM, Grande L, Irles JA, Cruz M, Nogales MC, Alcón JC, Robles A. Am J Gastroenterol; 2003 May 01; 98(5):1135-41. PubMed ID: 12809839 [Abstract] [Full Text] [Related]
20. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection. Petta S, Cammà C, Di Marco V, Cabibi D, Ciminnisi S, Caldarella R, Licata A, Massenti MF, Marchesini G, Craxì A. Antivir Ther; 2009 May 01; 14(5):631-9. PubMed ID: 19704165 [Abstract] [Full Text] [Related] Page: [Next] [New Search]